Dare´ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science ...
More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes. Diabetes is a chronic condition where the body does not produce or effectively use insulin. A lack of ...
End points were measured from baseline to week 52. Values are derived from an analysis of variance for the treatment policy estimand (top part of table) and a mixed-model-for-repeated-measures ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results